Back to search
Opioid-Induced Respiratory Depression
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Opioid-Induced Respiratory Depression trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Opioid-Induced Respiratory Depression trials you may qualify forThis study will evaluate whether quantitative pupillometry measurements can be used to identify children at risk for postoperative opioid-induced respiratory de…
This study is a Phase I clinical trial to assess the safety, tolerability, and pharmacokinetic (PK) and pharmacodynamic (PD) profiles with single intravenous (I…
n this pharmacokinetic/pharmacodynamic modelling study we will determine the ability of intranasal and intravenous naloxone and intravenous nalmefene to reverse…
This study is being conducted to evaluate the ability of the Respiratory Monitoring System (RMS) to detect and predict opioid induced respiratory depression (OI…
The investigators are studying the impact that opioids have on breathing during sleep in healthy participants and those diagnosed with obstructive sleep apnea.